BioDynamik, Inc

BioDynamik, Inc. is a medical device company specializing in innovative orthopedic-driven regenerative technologies for limb salvage and chronic wound care. The company develops advanced medical devices designed for Transverse Tibia Transport (TTT), a specialized surgical technique that leverages the body's natural healing mechanisms to restore perfusion and prevent amputation in patients with complex limb conditions. BioDynamik addresses critical clinical challenges including diabetic foot ulcers, peripheral artery disease (PAD), trauma-related limb damage, and infections that traditionally result in amputation. The flagship XT3 System has received FDA approval and represents a transformative approach to limb preservation by promoting tissue distraction, neovascularization, and vascularized tissue growth. The company collaborates with leading orthopedic surgeons, research institutions, and healthcare organizations to advance surgical techniques and technologies that offer hope to patients previously considered untreatable. BioDynamik holds ISO 13485 certification and maintains a commitment to innovation, with multiple U.S. patents issued for tissue distraction and automation systems.